Chemical Computing Group Releases New MOE Version 2003.02
MONTREAL, April 25, 2003
Chemical Computing Group announces the latest release of MOE - the Molecular Operating Environment, leading software for Life Sciences. MOE 2003.02 contains some major enhancements to its extensive range of comprehensive computational applications, which include tools for Bioinformatics, Cheminformatics, High Throughput Discovery, Protein Modeling, and Structure Based Design.
Among the many improvements to this version are the new pharmacophore consensus feature, additional pharmacophore schemes, protein library build scripts, enhanced protein consensus application including dendogram analysis options, and enhanced protein contacts panel. MOE can also now connect to a wide variety of relational database servers and share data directly with databases such as IBM DB2 Universal, Oracle, Microsoft SQL Server and MySQL, using a new set of SVL functions added for this purpose. The communication is via the Structured Query Language (SQL).
CCG's entire suite of drug discovery software applications has been adapted to run on, and exploit the power of IBM eServer pSeries systems running AIX, IBM's UNIX operating system, and xSeries server clusters running Linux compute server clusters, and to work with IBM's DB2 database technology.
Terry Higgins, CCG's Director of Research and Development, comments, "Once again, CCG's continuous research and development program has resulted in an improved package that will increase flexibility for scientists. Customer requests play an integral role in the research and development process at CCG and largely contributed to the direction of this version."
"CCG's Molecular Operating Environment exploits the power of IBM's eServer and DB2 technologies," said Anne-Marie Derouault, Director, Alliances and Distribution Channel Management, IBM Life Sciences. "Together, these advanced technologies create an end-to-end solution that can help transform drug discovery, enable researchers to respond quickly to change and add efficiencies to each step in the discovery process."
Chemical Computing Group Inc. is a leading provider of computational applications aimed at the drug discovery and design marketplace. CCG's flagship product is the award winning Molecular Operating Environment (MOE), which offers visualization, simulation, and methodology development in one package. MOE provides an integrated suite of powerful, yet intuitive chemistry software tools for HTS, Structure Based Design, Molecular modeling and Protein and Homology modeling as well as an embedded programming language for the rapid prototyping of scientific methods. Computational chemists, medicinal chemists and biologists use MOE in pharmaceutical companies, biotechnology companies, and universities worldwide.
CCG is based in Montreal, Canada, with offices in Lörrach, Germany and Cambridge, UK. For more information, visit www.chemcomp.com. Send E-mail to . In Asia, MOE is distributed by Ryoka Systems. Please visit www.rsi.co.jp/science.html or send E-mail to for more information.
MOE, SVL, and the Chemical Computing Group Inc. logo are trademarks of Chemical Computing Group Inc. or its licensors. IBM, AIX and DB2 are trademarks or registered trademarks of International Business Machines Corporation. UNIX is a registered trademark of The Open Group in the United States and other countries. Other product or brand names are trademarks or registered trademarks of their respective holders.